CWM
CarsonAllaria Wealth Management’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.5K | Sell |
277
-122
| -31% | -$5.93K | 0.01% | 229 |
|
|
2025
Q1 | $13.6K | Buy |
399
+31
| +8% | +$1.06K | 0.01% | 227 |
|
|
2024
Q4 | $14.5K | Hold |
368
| – | – | 0.01% | 219 |
|
|
2024
Q3 | $17.3K | Sell |
368
-68
| -16% | -$3.2K | 0.01% | 212 |
|
|
2024
Q2 | $23.5K | Hold |
436
| – | – | 0.01% | 182 |
|
|
2024
Q1 | $29.7K | Buy |
436
+23
| +6% | +$1.57K | 0.02% | 161 |
|
|
2023
Q4 | $25.9K | Sell |
413
-24
| -5% | -$1.5K | 0.02% | 152 |
|
|
2023
Q3 | $19.8K | Sell |
437
-74
| -14% | -$3.36K | 0.02% | 161 |
|
|
2023
Q2 | $28.7K | Sell |
511
-9
| -2% | -$505 | 0.02% | 144 |
|
|
2023
Q1 | $23.5K | Sell |
520
-75
| -13% | -$3.39K | 0.02% | 156 |
|
|
2022
Q4 | $24K | Sell |
595
-65
| -10% | -$2.62K | 0.02% | 142 |
|
|
2022
Q3 | $43K | Sell |
660
-4
| -0.6% | -$261 | 0.04% | 110 |
|
|
2022
Q2 | $40K | Buy |
664
+50
| +8% | +$3.01K | 0.04% | 114 |
|
|
2022
Q1 | $39K | Buy |
614
+564
| +1,128% | +$35.8K | 0.03% | 119 |
|
|
2021
Q4 | $4K | Buy |
+50
| New | +$4K | ﹤0.01% | 283 |
|